Brief: Kaleido Biosciences Provides Update On KB109 Clinical Data Timeline

Kaleido Biosciences

06/10/2020 12:34

Oct 6 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES PROVIDES UPDATE ON KB109 CLINICAL DATA
TIMELINE
    * KALEIDO BIOSCIENCES - UPDATED PROJECTIONS FOR ENROLLMENT
OF
MULTI-CENTER K031 CLINICAL STUDY INDICATED TOP-LINE DATA WILL BE
AVAILABLE IN Q1 OF 2021
    * KALEIDO BIOSCIENCES - CONTINUE TO EXPECT PRECLINICAL DATA
FROM
CO'S IMMUNO-ONCOLOGY, CARDIOMETABOLIC AND LIVER DISEASES
PROGRAMS THIS QUARTER
    * KALEIDO BIOSCIENCES - RESULTS OF OUR K032 CLINICAL STUDY
OF
KB109 CONTINUE TO BE EXPECTED IN Q1 OF 2021
    * KALEIDO BIOSCIENCES - GUIDANCE FOR CO'S OTHER PROGRAMS IS
UNCHANGED

Source text for Eikon:  ID:nGNX81F8ZS 
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))